NCT03733249 2023-09-26Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical StudyBellicum PharmaceuticalsPhase 1/2 Terminated187 enrolled 8 charts
NCT03301168 2022-07-12Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell TransplantBellicum PharmaceuticalsPhase 1/2 Active not recruiting120 enrolled
NCT00295880 2017-12-28Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic CancerMasonic Cancer Center, University of MinnesotaPhase 1/2 Terminated12 enrolled 14 charts
NCT00854945 2017-06-26Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AMLTraws Pharma, Inc.Phase 1/2 Completed36 enrolled